Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05564806
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Advanced Solid TumorsRelapsed Or Refractory Non-Hodgkin Lymphoma
Eucure (Beijing) Biopharma Co., Ltd 9
Early research (Phase 1)Study completedNCT03301207
What this trial is testing

Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Janssen Research & Development, LLC 25
Not applicableLooking for participantsNCT05376592
What this trial is testing

Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma

Who this might be right for
Pancreas AdenocarcinomaCachexia
Wake Forest University Health Sciences 100
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Testing effectiveness (Phase 2)Looking for participantsNCT04641247
What this trial is testing

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Who this might be right for
Ovarian NeoplasmsBreast Neoplasms
GlaxoSmithKline 37
Early research (Phase 1)WithdrawnNCT04054752
What this trial is testing

Vaccine Response With NT-I7

Who this might be right for
Breast CarcinomaColorectal AdenocarcinomaBladder Carcinoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT04619433
What this trial is testing

Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 48
Not applicableLooking for participantsNCT07598747
What this trial is testing

Prospective Study for the Development, Validation and Confirmation of a Multi-Cancer Early Detection Platform Through Whole-Genome Sequencing Analysis of Circulating DNA in Cancer and Non-Cancer Subjects

Who this might be right for
CancerHealthy Participants
Chang Gon Kim 6,000
Large-scale testing (Phase 3)Study completedNCT00111449
What this trial is testing

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Who this might be right for
Psoriasis
Amgen 600
Early research (Phase 1)Study completedNCT01364844
What this trial is testing

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Solid TumorColorectal CancerEndometrial Cancer
Daiichi Sankyo 42
Large-scale testing (Phase 3)Study completedNCT04812509
What this trial is testing

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Mabwell (Shanghai) Bioscience Co., Ltd. 708
Early research (Phase 1)Study completedNCT02594384
What this trial is testing

A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
OrphAI Therapeutics 62
Testing effectiveness (Phase 2)Study completedNCT00066092
What this trial is testing

Pegfilgrastim PBPC Mobilization Study

Who this might be right for
LymphomaHodgkin's LymphomaNon-Hodgkin's Lymphoma+2 more
Amgen 41
Early research (Phase 1)Study completedNCT02101580
What this trial is testing

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Polaris Group 21
Not applicableStudy completedNCT02503696
What this trial is testing

Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

Who this might be right for
Inflammatory Bowel DiseaseColorectal NeoplasmsDigestive System Diseases+2 more
Exact Sciences Corporation 697
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Early research (Phase 1)Ended earlyNCT00848601
What this trial is testing

Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma

Who this might be right for
Prostate CancerNon-Hodgkins Lymphoma
Astex Pharmaceuticals, Inc. 14
Early research (Phase 1)Study completedNCT03157167
What this trial is testing

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)

Who this might be right for
Kaposi SarcomaHIV Infections
Navidea Biopharmaceuticals 15
Early research (Phase 1)Not Yet RecruitingNCT07486700
What this trial is testing

The Phase I Study of SIG001 Antibody on Cancer Therapy.

Who this might be right for
Neoplams
Peking University 66
Early research (Phase 1)Study completedNCT02387307
What this trial is testing

RSIFN-co in Subjects With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellMelanoma+2 more
Sichuan Huiyang Life Science and Technology Corporation 42
Next Page